Correction: RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment

Related Posts

• RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment

  Background With the successful development of modern immunotherapy, immune checkpoint inhibitors (ICIs) are currently considered…

• Correction: Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

• 272 PD-L1 CAR engineered K-NK cells to target PD-L1+ or PD-L1- tumors

  Background Chimeric antigen receptor (CAR) engineered immune cells have shown unprecedented efficacy in Relapsed/Refractory hematological…